2 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
| Phase 1 | 1 | Suspended 1 |
Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma SBRT Sequential Surufatinib Combined With Immunotherapy - Biliary Tract Carcinoma | Phase 2 | Suspended | Zhejiang Cancer Hospital | 34 | 2024-02-01 | 2024-10-15 |
| Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer Chemotherapy, Immunotherapy, IMRT - Rectal Cancer, Radiotherapy | Phase 1 / Phase 2 | Suspended | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 30 | 2019-11-01 | 2024-01-03 |
Rectal Neoplasms (1)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Zhejiang Cancer Hospital (1)
China (2)
Luying Liu, M.D. (1)